Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Sjöholm, Therese; Korenyushkin, Alexander; Gammelgård, Gustav; Sarén, Tina; Lövgren, Tanja; Loskog, Angelica; Essand, Magnus; Kullberg, Joel; Enblad, Gunilla; Ahlström, Håkan

Sjöholm, Therese; Korenyushkin, Alexander; Gammelgård, Gustav; Sarén, Tina; Lövgren, Tanja; Loskog, Angelica; Essand, Magnus; Kullberg, Joel; Enblad, Gunilla; Ahlström, Håkan.

Afiliación

Sjöholm T; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. therese.sjoholm@surgsci.uu.se.
Korenyushkin A; Antaros Medical AB, Mölndal, Sweden.
Gammelgård G; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Sarén T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Lövgren T; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Loskog A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Essand M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Kullberg J; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Enblad G; Antaros Medical AB, Mölndal, Sweden.
Ahlström H; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Cancer Imaging ; 23(1): 46, 2023 May 19.

Article en En | MEDLINE | ID: mdl-37208774

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google